SCHEMBL27567973

SCHEMBL27567973

CCCCC(O)C(CCCC)C(=O)[C@H]1N=C(c2ccccc2)c2ccccc2N(C)C1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTCH1 P46531 3/20 0.42
RBPJ Q06330 2/20 0.42
GABRP O00591 1/20 0.42
GABRD O14764 1/20 0.42
GABRA1 P14867 1/20 0.42
GABRB1 P18505 1/20 0.42
GABRG2 P18507 1/20 0.42
GABRB3 P28472 1/20 0.42
GABRA5 P31644 1/20 0.42
GABRA3 P34903 1/20 0.42
GABRA2 P47869 1/20 0.42
GABRB2 P47870 1/20 0.42
GABRA4 P48169 1/20 0.42
GABRE P78334 1/20 0.42
GABRA6 Q16445 1/20 0.42
GABRG1 Q8N1C3 1/20 0.42
GABRG3 Q99928 1/20 0.42
GABRQ Q9UN88 1/20 0.42
PSEN1 P49768 1/20 0.42
PSEN2 P49810 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27567966 0.95 HDAC3 (0.41) NOTCH1RBPJGABRPGABRDGABRA1
SCHEMBL27587181 0.94 NOTCH1 (0.43) NOTCH1RBPJGABRPGABRDGABRA1
SCHEMBL27570564 0.92 NOTCH1 (0.40) NOTCH1RBPJGABRPGABRDGABRA1
SCHEMBL27567906 0.89 KCNH2 (0.41) NOTCH1RBPJGABRPGABRDGABRA1
SCHEMBL28747942 0.88 PSEN1 (0.43) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL28750577 0.88 NOTCH1 (0.37) NOTCH1RBPJGABRPGABRDGABRA1
SCHEMBL27577826 0.88 NOTCH1 (0.48) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27567874 0.86 NOTCH1 (0.39) NOTCH1RBPJPSEN1PSEN2APH1B
SCHEMBL27587101 0.81 OPRK1 (0.41) NOTCH1RBPJGABRPGABRDGABRA1
SCHEMBL27567902 0.80 CCKBR (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1399634-A Hydroxyalkanoyl aminolactams and related structure as inhibitors of A beta protein production BRISTOL MYERS SQUIBB PHARMA IN (US) 2003-02-26 CN disclosed